High Levels of Transduction of Human Dendritic Cells with Optimized SIV Vectors
Open Access
- 1 March 2002
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 5 (3), 283-290
- https://doi.org/10.1006/mthe.2002.0541
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Postentry Restriction to Human Immunodeficiency Virus-Based Vector Transduction in Human MonocytesJournal of Virology, 2001
- A New-Generation Stable Inducible Packaging Cell Line for Lentiviral VectorsHuman Gene Therapy, 2001
- Enhanced Transgene Expression in Cord Blood CD34+-Derived Hematopoietic Cells, Including Developing T Cells and NOD/SCID Mouse Repopulating Cells, Following Transduction with Modified TRIP Lentiviral VectorsMolecular Therapy, 2001
- Generation of a Stable Cell Line Producing High-Titer Self-Inactivating Lentiviral VectorsMolecular Therapy, 2001
- Characterization of novel safe lentiviral vectors derived from simian immunodeficiency virus (SIVmac251) that efficiently transduce mature human dendritic cellsGene Therapy, 2000
- Efficient Gene Transfer to Human Peripheral Blood Monocyte-Derived Dendritic Cells Using Human Immunodeficiency Virus Type 1-Based Lentiviral VectorsHuman Gene Therapy, 2000
- A Stable System for the High-Titer Production of Multiply Attenuated Lentiviral VectorsMolecular Therapy, 2000
- HIV-1 Genome Nuclear Import Is Mediated by a Central DNA FlapCell, 2000
- Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.The Journal of Experimental Medicine, 1994
- GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cellsNature, 1992